Patents by Inventor Shin-Young Ryu

Shin-Young Ryu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of aminoalkylbenzothiazepine derivatives
    Patent number: 11202783
    Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: December 21, 2021
    Assignee: CJ Healthcare Corporation
    Inventors: Hyungjin Jun, So Young Ki, Keunho Lee, Jin Woo Jung, Dong Hyun Kim, Chi Hye Park, Hyoung Rok Bak, Shin-Young Ryu, Ju Hyun Lee, Ho-Youl Lee, Won-Hyuk Jung, Dong Hyun Ko, Seungin Kim, Joonseok Byun, Jae Ho Yoo, Seunghee Ji
  • COMPOSITION FOR ERADICATING HELICOBACTER PYLORI
    Publication number: 20210196685
    Abstract: The present invention relates to a composition for eradicating Helicobacter pylori and a use thereof. The composition of the present invention maintains an intragastric pH at a certain level or more for a certain period of time or longer, thereby maximizing an action of amoxicillin and clarithromycin to show an excellent effect on eradicating Helicobacter pylori.
    Type: Application
    Filed: August 28, 2019
    Publication date: July 1, 2021
    Applicant: HK INNO.N CORPORATION
    Inventors: Bong Tae KIM, Dongkyu KIM, Eun Ji KIM, Ji Won LEE, Kyeongmin OH, Ahrong KIM, Geun Seog SONG, Shin-Young RYU, Eun Kyung KIM, Naree SHIN, Hyun Ji KANG, Jae Min KIM, Yu-Gyeong PARK, Haneul JEONG
  • Uses of benzimidazole derivative for nocturnal acid breakthrough
    Patent number: 11033532
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can more effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: June 15, 2021
    Assignee: HK INNO.N CORPORATION
    Inventors: Ha Jin Lee, Bong Tae Kim, Hyun Kim, Ji Yeon Nam, Jie Eun Park, Geun Seog Song, Shin Young Ryu, Shinichi Koizumi, Nobuyuki Takahashi, Masaomi Tajimi
  • USE OF AMINOALKYLBENZOTHIAZEPINE DERIVATIVES
    Publication number: 20200147101
    Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: July 20, 2018
    Publication date: May 14, 2020
    Applicant: CJ Healthcare Corporation
    Inventors: Hyungjin Jun, So Young Ki, Keunho Lee, Jin Woo Jung, Dong Hyun Kim, Chi Hye Park, Hyoung Rok Bak, Shin-Young Ryu, Ju Hyun Lee, Ho-Youl Lee, Won-Hyuk Jung, Dong Hyun Ko, Seungin Kim, Joonseok Byun, Jae Ho Yoo, Seunghee Ji
  • USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH
    Publication number: 20200069652
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can more effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 5, 2020
    Applicants: CJ HEALTHCARE CORPORATION, RaQualia Pharma Inc.
    Inventors: Ha Jin LEE, Bong Tae KIM, Hyun KIM, Ji Yeon NAM, Jie Eun PARK, Geun Seog SONG, Shin Young RYU, Shinichi KOIZUMI, Nobuyuki TAKAHASHI, Masaomi TAJIMI
  • Uses of benzimidazole derivative for nocturnal acid breakthrough
    Patent number: 10512635
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can mere effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: December 24, 2019
    Assignees: CJ Healthcare Corporation, RaQualia Pharma Inc.
    Inventors: Ha Jin Lee, Bong Tae Kim, Hyun Kim, Ji Yeon Nam, Jie Eun Park, Geun Seog Song, Shin Young Ryu, Shinichi Koizumi, Nobuyuki Takahashi, Masaomi Tajimi
  • USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH
    Publication number: 20180338954
    Abstract: The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can mere effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
    Type: Application
    Filed: June 8, 2016
    Publication date: November 29, 2018
    Applicants: CJ HEALTHCARE CORPORATION, RaQualia Pharma Inc.
    Inventors: Ha Jin LEE, Bong Tae KIM, Hyun KIM, Ji Yeon NAM, Jie Eun PARK, Geun Seog SONG, Shin Young RYU, Shinichi KOIZUMI, Nobuyuki TAKAHASHI, Masaomi TAJIMI
  • Amino-phenyl-sulfonyl-acetate derivatives and use thereof
    Patent number: 10047041
    Abstract: The present invention relates to a novel amino-phenyl-sulfonyl-acetate derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating diabetes comprising the same as an active ingredient.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: August 14, 2018
    Assignee: CJ HEALTHCARE CORPORATION
    Inventors: Jae Ho Yoo, Seung Chan Kim, Soo Yeon Jung, Hyoung Rok Bak, Young Mee Chung, Sung Jun Kim, Sook Kyung Park, Seog Beom Song, Shin-Young Ryu, Mi Young Yoon, Dong Hyun Ko, Sun Young Park, Chi Hye Park, Nak Hyun Choi
  • NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVES AND USE THEREOF
    Publication number: 20170247320
    Abstract: The present invention relates to a novel amino-phenyl-sulfonyl-acetate derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating diabetes comprising the same as an active ingredient.
    Type: Application
    Filed: July 14, 2015
    Publication date: August 31, 2017
    Applicant: CJ Healthcare Corporation
    Inventors: Jae Ho Yoo, Seung Chan Kim, Soo Yeon Jung, Hyoung Rok Bak, Young Mee Chung, Sung Jun Kim, Sook Kyung Park, Seog Beom Song, Shin-Young Ryu, Mi Young Yoon, Dong Hyun Ko, Sun Young Park, Chi Hye Park, Nak Hyun Choi